Epidermal growth factor receptor directed therapy in head and neck cancer

This publication has 143 references indexed in Scilit:

• ZD6474, a Potent Inhibitor of Vascular Endothelial Growth Factor Signaling, Combined With Radiotherapy
  Clinical Cancer Research, 2004
• Tumor Cell and Endothelial Cell Therapy of Oral Cancer by Dual Tyrosine Kinase Receptor Blockade
  Cancer Research, 2004
• Genome‐wide profiling of oral squamous cell carcinoma
  The Journal of Pathology, 2004
• EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinib
  Proceedings of the National Academy of Sciences, 2004
• EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
  Science, 2004
• Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib
  New England Journal of Medicine, 2004
• Antiproliferative, antiangiogenic and proapoptotic activity of h‐R3: A humanized anti‐EGFR antibody
  International Journal of Cancer, 2002
• Amplification of ERBB oncogenes in squamous cell carcinomas of the head and neck
  European Journal Of Cancer, 1996
• Analysis of gene amplification in head‐and‐neck squamous‐cell carcinomas
  International Journal of Cancer, 1991
• The stimulation of epidermal proliferation by a specific protein (EGF)
  Developmental Biology, 1965